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Abstract
Until recently, Q fever was notiﬁed in very low numbers annually in Denmark and it was always considered to be acquired abroad. Pre-
liminary reports now describe Coxiella burnetii in milk samples from Danish dairy cattle. Serum samples of a large cohort of farmers, vet-
erinarians, inseminators and hoof trimmers, all having occupational contact with dairy cattle, were tested for the presence of IgG to
phase I and phase II antigens of C. burnetii. In 39 of 359 individuals studied (11%), the presence of antibodies to C. burnetii was found.
Veterinarians had the highest seropositivity rate (36%). This survey suggests that C. burnetii is a recently recognized domestic infection
in Denmark and that risk of infection is associated with occupation.
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Introduction
Q fever is a zoonotic infection caused by the obligate intra-
cellular organism Coxiella burnetii [1]. C. burnetii can be found
in high numbers in amniotic ﬂuid, placenta and foetal mem-
branes as well as in milk, urine and faeces of infected animals
[2–4]. The primary mode of human infection involves the aer-
osol route [5], and the domesticated animals most often
implicated in human disease are sheep, cattle and goats.
Occasional outbreaks have been described in many countries,
although the majority of cases are probably not diagnosed as
a result of a subclinical or nonspeciﬁc self-limiting clinical
course of the infection. Patients that have been infected with
C. burnetii remain seropositive and are considered to be
immune to acute Q fever for at least some years. Certain
professions have an elevated risk of exposure to C. burnetii
because of their occupational contact with animals [6–9].
C. burnetii is distributed in wild and domesticated animals
worldwide [10]. Earlier literature suggested New Zealand
and the Scandinavian countries to be free of Q fever, but
human cases linked to sheep farming have been published
from Sweden [6,11] and, recently, C. burnetii has been
reported as one of the causes of abortion in Danish sheep
[12]. Until recently, Q fever in Denmark was diagnosed in
very low numbers annually and it was always consodered to
be acquired abroad. However, we have now encountered
veterinarians and farmers with Q fever without travel his-
tory, and C. burnetii has been identiﬁed in placenta material
from aborting cows [13]. Preliminary reports suggested a
high prevalence of C. burnetii in milk samples from Danish
dairy cattle. We decided to perform a seroepidemiological
survey in a sentinel cohort of farmers, veterinarians, insemi-
nators and hoof trimmers in one of the main agricultural
activities in Denmark because all the included individuals
have an occupational contact with dairy cattle.
Materials and Methods
A total of 359 adult individuals (age > 18 years) considered
to be at potential risk of contracting an infection with C. bur-
netii because of close contact with dairy cattle were studied.
The sentinel group consisted of farmers, veterinarians,
inseminators and hoof trimmers. The study was approved by
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the Regional Scientiﬁc Ethics Committee (N-20070060), and
all subjects provided their informed consent. Blood samples
were obtained between January and October 2008. The farm
residents (n = 163) came from 100 randomly selected farms,
the veterinarians (n = 87) were recruited from the associa-
tion of veterinarians working with dairy cattle as their main
occupation (membership 120), the inseminators (n = 95)
were recruited from the association of Danish inseminators
(membership 182) and, lastly, hoof trimmers (n = 14) were
also included.
Mailed questionnaires recorded the participants’ demo-
graphic data, occupation, travel history and clinical illness for
the last 2 years. The 359 participants included 101 women
and 258 men, aged 18–69 years. There was no difference in
age, sex or occupation between the individuals who agreed
to participate and those who did not.
Serum samples were tested for the presence of IgG react-
ing with phase I and phase II antigen of C. burnetii strain Nine
Mile using a commercially available immunoﬂourescence
assay (Focus Diagnostics, Cypress, CA, USA). The test was
performed according to the manufacturer’s instructions in a
certiﬁed laboratory at Statens Serum Institut, Copenhagen,
Denmark. On the basis of testing serial dilutions, a semiquan-
titative titre was obtained. A sample was considered positive
for antibodies against C. burnetii when a titre of IgG phase
I ‡ 512 or IgG phase II ‡ 1024 was determined. These cut-
off levels have previously been determined based on a study
involving 158 healthy blood donors (assumed not to have Q
fever) from three city areas of Denmark [14]. In 27 cases, an
indeterminate result was obtained with the ﬁrst sample (anti-
phase I and anti-phase II antigen IgG titres of 128–256 and
256–512, respectively) and a second test was performed
after 3 months, although a seroconversion to positivity was
not observed in any of these cases.
In all cases of elevated IgG titres, an additional assessment
of sedimentation rates, C-reactive protein, liver function and
white blood cell counts was performed.
Results
In 39 of 359 study individuals (11%) anti-C. burnetii IgG was
detected. C. burnetii antibodies were found in 31 of 87 veteri-
narians (36%), in two of 15 inseminators (2%), in ﬁve of 163
farmers (3%) and in one of 14 hoof trimmers (7%). Among the
seropositive individuals, there were 20 with a positive IgG
phase I titre and 26 with a positive IgG phase II titre. The titres
of IgG antibodies varied; few very high values were observed
(Table 1). There was no correlation between age and the IgG
positivity rate (3.7% aged 18–29 years, 16.5% aged 30–
39 years, 7.7% aged 40–49 years, 15.9% aged 50–59 years, and
5.6% aged 60–69 years were positive). None of the seroposi-
tive subjects had signs or symptoms of acute Q fever infection
at the time of examination, and biochemical parameters were
within normal range in all cases. In one case, a cardiac murmur
was detected and, by echocardiography, a moderate insufﬁ-
ciency of the mitral valves without excrescences was
observed. The IgG phase I titre was 4096 and a diagnosis of
possible Q fever endocarditis was made. In all of the remaining
38 cases, no abnormalities were found.
The percentage of IgG-positive subjects among pooled
groups was higher in males (64%) than in females (36%); in
addition, the frequency of antibodies among veterinarians was
higher in males (58%) than in females (42%), although the dif-
ference between positives in the male and in the female group
was not statistically signiﬁcant in the pooled groups (p 0.25) or
among the veterinarians (p 0.69). Twenty-three percent of the
seropositive individuals and 30% of the seronegative individuals
did not have any travel history (traveling out of country) for
the last 2 years. There was no statistically signiﬁcant difference
(p 0.32) between these two groups. We found 51% of the
seropositive individuals and 40% of the seronegative individuals
with at least one episode of inﬂuenza-like symptoms during
the last 2 years. There was no statistically signiﬁcant difference
(p 0.21) between these two groups.
Discussion
C. burnetii is distributed worldwide, with the exception of
New Zealand [9]. The earlier availabale literature reported
that the Scandinavian countries were free of Q fever and
that the few sporadic cases were acquired abroad. It
has been suggested that Denmark and its Scandinavian
neighbours are the only exceptions with respect to the
TABLE 1. Titre distribution of antibodies against Coxiella
burnetii phase I and phase II antigens among 359 high-risk
subjects in Denmark
Titre
Phase I antigen Phase II antigen
n % N %
<256 309 86.0 259 72.1
256 30 8.4 40 11.1
- - - - - - - - - - - - - -
512 9 2.5 34 9.5
- - - - - - - - - - - - - -
1024 8 2.2 23 6.4
2048 2 0.6 1 0.3
4096 1 0.3 2 0.6
Totals 359 100.0 359 100.0
Dashed lines denote the separation between seronegative and seropositive sub-
jects based on the cut-off criteria used in the present study.
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worldwide distribution of Q fever [15]. However, seroepide-
miological studies have revealed antibodies against C. burnetii
in humans from all over Sweden [10,11] and C. burnetii has
been reported as one of the causes of abortion in Danish
sheep [12]. This survey suggests that the Q fever situation in
Denmark is similar to that of other countries and that C. bur-
netii infection is a domestic infection in Denmark. There was
no difference in seropositivity rates between individuals with
and without travel history, which supports our hypothesis
that study individuals were infected in Denmark.
The question arises as to whether the increase in the
number of diagnosed cases is the result of a recent introduc-
tion of Q fever into Denmark or the consequence of
increased surveillance and assessment of antibodies in
patients with a perceived increased risk. The observation of
no correlation between age and seropositivity among adults
with risk exposure suggests that C. burnetii has not been
widespread among Danish dairy cattle for a long time, but
may have been introduced recently.
By contrast, reports from other countries with Q fever
endemic for many years describe an increased seropositivity
at increasing age [16,17].
The survey conducted in the present study demonstrated
the highest prevalence in veterinarians, which is in agreement
with observations from many other countries [8,11,18,19],
whereas surprisingly few farmers and inseminators had anti-
bodies despite their well recognized daily contact with dairy
cattle. In Sweden, 13% of veterinarians and 28% of sheep
farmers tested had antibodies against C. burnetii compared to
7% of hospital employees [11]; 13.5% of Japanese [8] and
9.5% of Australian veterinarians [18] had antibodies. Approx-
imately 25% of Swiss veterinarians were positive in contrast
to 3.5% of blood donors [19], and a recent survey found
22.2% seropositivity among US veterinarians [20]. It is difﬁ-
cult to compare the results of our survey with those of
serological studies in other countries because different cut-
off criteria were used. We used very high cut-off levels and
we found an almost three-fold higher percentage of seropos-
itive veterinarians (36%) than that observed in our neigh-
bouring country, Sweden.
It is obvious that the value of the cut-off titre used as a cri-
terion for seropositivity will have a great inﬂuence on the
results of any study. Differences between assays and between
populations make it difﬁcult to directly compare reports from
different countries. Consequently, although using a commer-
cial assay from the USA, we decided to use cut-off values that
had been determined on the basis of results obtained from a
control group of healthy adults from major cities in Denmark.
To increase the positive predictive value of the test in a
presumed low endemic area, the cut-off values had been
selected rather conservatively as one titre above that of any
sample obtained from healthy urban controls [14].
We acknowledge that the results obtained in the present
study likely represent the low end of the true seropreva-
lence, and that this deﬁnition will potentially make the rate
of seropositivity in our study cohort appear to be lower
than than that found in other surveys.
Only 3% of Danish farmers were seropositive. This is a
low percentage, especially when milk samples of 61% of
Danish diary cattle have been found to be positive for
C. burnetii (J. Agerholm, unpublished data). In other coun-
tries, this percentage was much higher: 28.5% of Swedish
sheep farmers [6] and 27% of English farmers [9] were
seropositive, and 17.8% of Polish farmers had IgG phase I
antibodies [21]. In Milwaukee, the seropositivity among resi-
dents of dairy farms was much higher (28.5%) than in a
local control group (2.2%) [22], which was also observed in
Maryland (15.3% vs. 0.15%) [23]. The reason why veterinar-
ians are more exposed than farmers may be that the veter-
inarians work with sick animals also during parturition and
with various types of livestock from many different farms,
whereas the farmers usually work with healthy animals and
with one livestock only. We have no information on other
potential sources of exposure (e.g. dogs or cats), which
could explain a difference between risk groups. However, it
is unlikely that dog or cat ownership should inﬂuence the
probability of developing antibodies against C. burnetii [24].
However, other unassessed differences in exposure
between veterinarians and farmers or controls cannot be
excluded.
Among 39 participants with signiﬁcant, elevated titres of
IgG antibodies against C. burnetii, only one case of possible
chronic Q fever was observed. All other subjects were with-
out symptoms and biochemical measurements were all
within normal ranges. We did not ﬁnd a higher prevalence of
clinical illness in the seropositive group within 2 years prior
to the study as compared to the seronegative group.
Because the main domestic animals in Denmark, apart from
pigs, are cattle, and only very few sheep and goat farms exist,
another explanation could be that Q fever acquired from
cattle has a milder clinical course. Although clinical illness
appears to be very rare, we should consider the possibility of
Q fever in cases of unexplained illness in patients with occupa-
tional contact to cattle’, especially veterinarians.
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